HPLC vs Mass Spectrometry: Peptide Purity Testing Explained

HPLC (High-Performance Liquid Chromatography) and mass spectrometry answer two fundamentally different questions about a peptide sample. HPLC answers “how pure is it?” by separating the components of a mixture and calculating what percentage is the target compound. Mass spectrometry answers “is it the right molecule?” by measuring the molecular weight of the sample with enough precision to confirm or reject its identity.

These are not interchangeable tests. A peptide could show 99% purity on HPLC but be the entirely wrong compound – the chromatogram would still show a single clean peak. Conversely, mass spectrometry could confirm the correct molecular weight but tell you nothing about whether the sample is 60% pure or 99% pure. Every credible Certificate of Analysis (COA) includes both, and any COA that reports only one should be treated with caution.

Feature	HPLC	Mass Spectrometry
Primary question	How pure is the sample?	Is this the right molecule?
Output	Chromatogram (peaks) + purity %	Mass spectrum + molecular weight
What it detects	Peptidic impurities (deletion sequences, truncations, oxidation products)	Molecular identity, adducts, fragments
What it misses	Non-UV-absorbing contaminants, salts, water, endotoxins	Quantity/proportion of impurities, non-peptidic contaminants
Detection method	UV absorbance at 214-220 nm	Ionisation + mass-to-charge ratio
Typical accuracy	Can detect impurities below 1% of sample	Molecular weight to within 0.01-0.1 Da (high-resolution)
Abbreviation on COAs	RP-HPLC or HPLC	MS, ESI-MS, MALDI-TOF, or LC-MS

The bottom line: HPLC quantifies purity while mass spectrometry confirms identity – a credible peptide COA always includes both.

Reverse-phase HPLC (RP-HPLC) is the primary analytical method for measuring peptide purity. The technique separates the components of a sample based on their hydrophobicity – how strongly each molecule interacts with a water-repelling surface – and then measures how much of the total sample is the target peptide versus everything else.

The Physical Process

A small quantity of peptide is dissolved in solvent (typically water and acetonitrile with 0.1% trifluoroacetic acid) and injected into a narrow column packed with tiny silica particles coated in C18 hydrocarbon chains. These particles are typically 2-5 micrometres in diameter. The mobile phase – a gradient shifting from mostly water to mostly organic solvent – is then pumped through the column at high pressure.

As the gradient shifts, different compounds release from the column at different times depending on their chemical properties. The target peptide, deletion sequences (peptides with missing amino acids from synthesis errors), truncated sequences, oxidation products, and other impurities all travel through the column at slightly different rates. A UV detector at the end of the column monitors what comes out and when.

Why 214 nm Detection Matters

The UV detector is set to 214-220 nm because this is where the peptide bond itself absorbs ultraviolet light most strongly. The peptide bond has a molar extinction coefficient of approximately 923 M^-1 cm^-1 at 214 nm, as measured by Kuipers and Gruppen in 2007. This wavelength makes detection essentially universal for all peptides regardless of their amino acid sequence, because every peptide contains peptide bonds. A COA that reports detection at a different wavelength – say 280 nm, which only detects aromatic amino acids like tryptophan and tyrosine – is using a method that will miss peptides without those residues.

Reading the Chromatogram

The output of an HPLC run is a chromatogram: a graph with retention time on the x-axis and signal intensity on the y-axis. The target peptide appears as the largest peak. Purity is calculated by dividing the area of the main peak by the total area of all peaks in the chromatogram. A sample showing 98.5% purity means the main peak represents 98.5% of the total UV-absorbing material detected.

What HPLC Cannot Detect

Understanding HPLC’s blind spots is as important as understanding its capabilities. HPLC measures only UV-absorbing material. It cannot detect salts, counterions (such as trifluoroacetate/TFA), residual water, residual solvents, bacterial endotoxins, or heavy metals. A sample could be 99% pure by HPLC but contain significant non-peptidic contamination that the test simply cannot see. This is exactly why separate tests for endotoxins (LAL test), heavy metals, and net peptide content exist – and why comprehensive COAs include them alongside HPLC purity.

HPLC also cannot tell you whether the main peak is actually your target peptide or a different compound with similar hydrophobic properties. Two structurally different peptides can co-elute – meaning they exit the column at the same time and appear as a single peak. This is why mass spectrometry is essential as a complementary test: it confirms the identity that HPLC cannot.

The bottom line: HPLC is the standard purity measurement for peptides, but it only sees UV-absorbing material and cannot confirm molecular identity on its own.

Mass spectrometry confirms a peptide’s identity by measuring its molecular weight with high precision. If HPLC tells you “the sample is 98.7% one compound,” mass spectrometry tells you “that compound has a molecular weight of 1,419.53 Da, which matches the expected weight of BPC-157.” Without this confirmation, a high HPLC purity number is essentially meaningless – you could be looking at a very pure sample of the wrong peptide.

Two Main Ionisation Methods

Mass spectrometry works by ionising molecules (giving them an electrical charge) and then measuring their mass-to-charge ratio (m/z). Two ionisation methods dominate peptide analysis, each with distinct strengths.

Electrospray Ionisation (ESI) is the method used in LC-MS (liquid chromatography coupled to mass spectrometry). The peptide solution is sprayed through a charged needle, producing a fine mist of charged droplets. As the solvent evaporates, multiply charged peptide ions are released into the mass analyser. ESI’s key advantage is that it creates ions in multiple charge states, which means it can detect larger peptides and proteins that would be outside the range of single-charge methods. ESI also tends to favour hydrophobic peptides, which is useful given that many research peptides fall into this category.

MALDI-TOF (Matrix-Assisted Laser Desorption/Ionisation – Time of Flight) works differently. The peptide is mixed with a crystalline matrix material and dried onto a metal plate. A laser pulse then hits the crystal, causing the matrix to absorb the energy and transfer it to the peptide molecules, launching them into the mass analyser as singly charged ions. The time it takes each ion to reach the detector (the “time of flight”) correlates directly with its mass. MALDI-TOF is fast, sensitive, and requires very small sample amounts, but because it generates only singly charged ions, it has practical upper mass limits for peptide detection.

Feature	ESI (LC-MS)	MALDI-TOF
Ionisation	Multiply charged ions from solution spray	Singly charged ions from laser-excited matrix
Sample introduction	Continuous flow from LC system	Co-crystallised on metal plate
Best for	Complex mixtures, larger peptides/proteins, hydrophobic compounds	Known/confirmed peptides, rapid screening, very small samples
Sample amount needed	More (unless nano-LC is used)	Very small (picomole range)
Common on COAs	Yes – often as LC-MS	Yes – often standalone
Adduct peaks	[M+H]+, [M+2H]2+, [M+Na]+	[M+H]+, [M+Na]+, [M+K]+

What the Mass Spectrum Tells You

A mass spectrum shows m/z values on the x-axis and signal intensity on the y-axis. The dominant peak should correspond to the expected molecular weight of the target peptide. On a COA, you will typically see a reported “observed mass” or “found mass” alongside an “expected mass” or “calculated mass.” These should match to within the instrument’s precision – typically within 0.1 Da for standard instruments and within 0.01 Da for high-resolution systems.

You may also see sodium adduct peaks ([M+Na]+) and potassium adduct peaks ([M+K]+), which appear at the expected molecular weight plus 22 Da or 38 Da respectively. These are normal artefacts of the ionisation process, not impurities, and they come from trace sodium and potassium in the solvents or buffers used during analysis.

The bottom line: Mass spectrometry is the only way to confirm a peptide’s molecular identity, but it cannot replace HPLC for measuring how much of the sample is the target compound.

LC-MS (Liquid Chromatography-Mass Spectrometry) couples an HPLC system directly to a mass spectrometer, running both analyses on the same sample in a single pass. This is the most informative single analytical run available for peptide characterisation because it combines separation, quantification, and identification simultaneously.

In an LC-MS system, the peptide sample first passes through the HPLC column, which separates the components. As each component exits the column, it passes directly into the mass spectrometer via an ESI interface. This means the mass spectrometer can identify each peak in the chromatogram individually – not just the main peak but also the impurity peaks. If a COA reports LC-MS results, it tells you both the purity and the molecular identity of the compound in a single integrated dataset.

LC-MS also solves the co-elution problem. If two different compounds happen to exit the HPLC column at the same time (appearing as one peak on a standard HPLC run), the mass spectrometer can still distinguish them by their different molecular weights. This makes LC-MS more reliable than standalone HPLC for complex or unfamiliar samples.

The bottom line: LC-MS provides both purity and identity data in a single correlated run, making it the most reliable analytical method for peptide quality verification.

HPLC purity and net peptide content (NPC) are both reported as percentages, but they measure completely different things. Confusing them is one of the most common errors in evaluating peptide quality, and the distinction directly affects any concentration calculations.

HPLC purity measures the fraction of UV-absorbing peptidic material that is the target compound. A 98% purity means that of all the peptide-like material detected, 98% is the desired sequence and 2% is other peptides (deletion sequences, truncated sequences, oxidation products).

Net peptide content measures how much of the total powder weight is actually peptide material of any kind. Lyophilised peptide powder is never 100% peptide – it also contains counterions (typically TFA), residual water, and traces of residual solvent from purification. NPC typically ranges from 60-90% depending on the sequence, with peptides containing more basic amino acids (arginine, lysine, histidine) binding more TFA counterions and therefore having lower NPC values.

The practical formula for calculating actual target peptide mass from a weighed sample is: Target peptide mass = Gross weight x NPC (%) x HPLC purity (%). For example, 10 mg gross weight at 80% NPC and 98% purity gives you 7.84 mg of actual target peptide – not 9.8 mg as you might assume from the purity figure alone. NPC is typically determined by amino acid analysis (AAA) or elemental analysis, and both figures should appear on a comprehensive COA.

The bottom line: A peptide can be 99% pure by HPLC while only 65% of the powder weight is actually peptide material – always check net peptide content alongside purity.

HPLC and mass spectrometry together cover purity and identity, but a comprehensive quality assessment requires additional tests that neither instrument can perform.

• Endotoxin testing (LAL test): Bacterial endotoxins are invisible to both HPLC and mass spectrometry in routine peptide analysis. The Limulus Amebocyte Lysate (LAL) test specifically detects these pyrogens, which can cause severe immune reactions. This test is critical for any peptide intended for parenteral research applications.
• Heavy metals screening: Neither HPLC nor standard MS protocols will detect trace metal contamination. Separate inductively coupled plasma mass spectrometry (ICP-MS) is needed to screen for lead, mercury, arsenic, and cadmium.
• Sterility and bioburden: Microbial contamination is completely undetectable by either technique. Standard microbiological culture methods or membrane filtration are required.
• Residual solvent analysis: Solvents from the synthesis or purification process (acetonitrile, TFA, DMF) are typically measured by gas chromatography (GC), not HPLC or MS.

The bottom line: HPLC and MS cover purity and identity, but endotoxin, heavy metal, sterility, and residual solvent testing require entirely separate analytical methods.

Peptide purity grades range from crude (below 70%) to ultra-high (99%+), and the grade required depends entirely on the research application. Overspending on pharmaceutical-grade purity for an ELISA screen wastes budget, while running an in vivo study with desalted-grade material compromises data integrity.

Purity Grade	HPLC Purity	Typical Application
Crude	<70%	Antibody production, ELISA screening
Desalted	~75-85%	Cell-based assays, non-quantitative work
Research grade	95%+	In vitro studies, binding assays, dose-response
Pharmaceutical grade	98%+	In vivo studies, clinical trials, GMP manufacturing
Ultra-high purity	99%+	Reference standards, pharmacokinetic studies

The purity grade directly affects research reproducibility. At 90% purity, 10% of the sample is impurities that may have their own biological activity, introduce batch-to-batch variation, or interfere with dose calculations. A study conducted with 90% pure peptide at a nominal 1 mg/mL concentration is actually working with approximately 0.9 mg/mL of target compound – and potentially less when net peptide content is factored in.

The bottom line: Research-grade peptides require at least 95% HPLC purity, and any quantitative or in vivo work should target 98% or higher.

A COA missing a chromatogram image, omitting mass spectrometry confirmation, or reporting detection at 280 nm instead of 214 nm should be treated as unreliable until independently verified. These are the most common method-level warning signs that distinguish credible analytical reports from inadequate or fabricated ones.

Signs of a Credible COA

• Both HPLC purity and mass spectrometry identity results included
• Actual chromatogram and/or mass spectrum images included – not just numbers
• Method parameters stated (column, mobile phase, wavelength, gradient)
• Batch/lot number that can be cross-referenced
• Third-party lab attribution with independently verifiable reference number
• Observed mass matches expected mass within instrument tolerance

Warning Signs

• Purity number only, with no chromatogram image or method details
• HPLC results without any mass spectrometry confirmation
• “In-house testing” with no third-party verification mechanism
• Suspiciously round purity figures (exactly 99.00% across multiple peptides)
• No batch or lot number, or a number that cannot be independently verified
• Testing laboratory that does not appear to exist independently
• Detection wavelength reported as 280 nm (misses non-aromatic peptides)

For a step-by-step guide to verifying COA claims – including how to use the Janoshik Analytical verify portal – see our COA reading and verification guide.

The bottom line: A COA without both HPLC chromatogram and mass spec data, method details, and a verifiable batch number should not be trusted at face value.

Amino acid analysis (AAA), capillary electrophoresis, size exclusion chromatography, and tandem mass spectrometry (MS/MS) each address gaps that standard HPLC and single-stage MS cannot cover. These supplementary methods may appear on more comprehensive COAs and are worth understanding.

• Amino acid analysis (AAA): Determines net peptide content and confirms the amino acid composition of the peptide. The sample is hydrolysed into individual amino acids, which are then quantified. This is the standard method for determining NPC and verifying that the correct amino acids are present in the expected ratios.
• Capillary electrophoresis (CE): An alternative separation technique that can resolve very hydrophilic peptides that RP-HPLC handles poorly. Useful as a secondary purity check or for peptides with unusual charge properties.
• Size exclusion chromatography (SEC): Separates by molecular size rather than hydrophobicity. Particularly useful for detecting peptide aggregation (clumping) or dimerisation, which RP-HPLC may not resolve.
• Tandem mass spectrometry (MS/MS): Goes beyond molecular weight to provide sequence-level information by fragmenting the peptide and analysing the resulting pieces. This is the definitive test for confirming the amino acid sequence, not just the total mass.

The bottom line: AAA, CE, SEC, and MS/MS each fill specific analytical gaps – their presence on a COA signals a higher standard of quality assurance than HPLC and MS alone.

Is HPLC or mass spectrometry more important?

Neither is more important – they answer different questions and both are necessary. If forced to choose, HPLC provides more practically useful information for routine quality checking (the purity percentage), but mass spectrometry is the only way to confirm identity. A 99% pure sample of the wrong peptide is worse than a 95% pure sample of the right one.

What HPLC purity percentage should a COA show?

For most research applications, the HPLC chromatogram should show a main peak representing 95% or more of total UV-absorbing material. For quantitative work, dose-response experiments, or any in vivo application, 98% or higher is the standard expectation. Be cautious of COAs reporting exactly 99.00% across multiple different peptides – genuine analytical results almost always include decimal variation (e.g. 98.73%, 99.14%) because real measurements are never perfectly round.

Can I do my own HPLC or MS testing?

Independent third-party testing is available through laboratories that specialise in peptide analysis. Testing typically costs in the range of $50-300 per sample depending on the tests requested. The key requirement is that the testing laboratory must be genuinely independent of the vendor – never use a testing service recommended by the supplier, as this creates a conflict of interest.

What does “co-elution” mean and why does it matter?

Co-elution occurs when two or more chemically distinct compounds exit the HPLC column at the same time, appearing as a single peak rather than separate peaks. This means the purity percentage may be artificially inflated – what appears to be a 99% pure main peak may actually contain two different peptides at 85% and 14% that happen to have similar hydrophobic properties. LC-MS (where mass spectrometry is coupled to the HPLC) can detect co-eluting species by their different molecular weights, which is one reason LC-MS is considered more reliable than standalone HPLC.